Work

FID-007 in combination with cetuximab in recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.6020

Authors: Guilherme Rabinowits, Christine H. Chung, Aditya V. Shreenivas, Eric S. Nadler, Donald A. Richards, Nabil F. Saba, Ray Yin, Jorge J. Nieva, Jacob Stephen Thomas

Institutions: Moffitt Cancer Center, City Of Hope National Medical Center, Texas Oncology, Winship Cancer Institute, University of Southern California, USC Norris Comprehensive Cancer Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162486309

Cites:

Cited by:

Related to: